Blog

Alex Therapeutics has signed an unique guarantee with Navamedic for the advance of a Significant other App to support within the remedy of Parkinson’s Sickness


STOCKHOLM, Sept. 12, 2024 /PRNewswire/ — Navamedic ASA (OSE: NAVA), a Nordic pharma corporate and significance supplier of high quality merchandise to hospitals and pharmacies, has partnered with Alex Therapeutics, a virtual condition supplier of illness and drug significant other apps, to support in Parkinson’s remedy control. The app shall be evolved via Alex Therapeutics to backup sufferers on Flexilev®, a prescription remedy for Parkinson’s illness.

The untouched significant other app supplies healing control backup that addresses the precise wishes and demanding situations of family residing with Parkinson’s illness. The app enhances the after week dose dispenser, OraFID®, containing Flexilev®, providing a singular aggregate to backup sufferers to stick to express and individualized remedy regimens.

Parkinson’s illness is a neurodegenerative disease related to lack of motor abilities and non-motor purposes reminiscent of cognitive talent, which is able to put together it tough to supremacy remedies. Virtual condition gear lend a possibility to backup sufferers with purposes reminiscent of reminders and remedy timbers.

“We are excited to collaborate with Alex Therapeutics to enhance the lives of Parkinson’s patients through the companion app. This partnership not only reflects our commitment to making the treatment more accessible and manageable, but also underscores our dedication to easing the burden that patients face in their day-to-day care,” stocks Kathrine Gamborg Andreassen, CEO of Navamedic.

CEO and Founding father of Alex Therapeutics, John Drakenberg, states, “We are proud to partner with Navamedic to bring this tailored solution to the Parkinson’s community. Our goal is to empower patients to manage their treatments effectively, for better symptom relief and improved quality of life.”

The significant other app is about to be introduced in Sweden, Norway and Denmark within the coming presen, with plans for additional international enlargement.

About Navamedic

Navamedic ASA is a Nordic pharma corporate and significance supplier of high quality merchandise, brought to hospitals and thru pharmacies, assembly the precise wishes of sufferers and shoppers via leveraging its extremely scalable marketplace get right of entry to platform, important section competence and native wisdom. Navamedic is found in all of the Nordic international locations, the Baltics and Benelux, with gross sales illustration in the United Kingdom and Greece. Navamedic is headquartered in Oslo, Norway, and indexed at the Oslo Accumulation Alternate (ticker: NAVA). Senidose is an absolutely owned subsidiary of Navamedic. For more info, discuss with: www.navamedic.com

About Alex Therapeutics

Alex Therapeutics is a virtual condition corporate based totally in Stockholm and Boston that companions with pharmaceutical firms to backup family with remedy and disease-related psychological condition demanding situations thru clinically validated significant other apps. Alex Therapeutics focuses on oncology and uncommon sicknesses, which normally entail complicated remedy regimes and mental misery. The corporate has a powerful regulatory crew to backup CE and FDA approbation in addition to medical proof week for SaMDs. For more info, discuss with: www.alextherapeutics.com

Media Contacts

Navamedic
Kathrine Gamborg Andreassen, CEO
[email protected]  

Alex Therapeutics
Meera Montan, Director of Expansion
[email protected] 

This data used to be dropped at you via Cision http://news.cision.com

https://news.cision.com/alex-therapeutics/r/alex-therapeutics-has-signed-an-exclusive-agreement-with-navamedic-for-the-development-of-a-companio,c4036593

Please see information are to be had for obtain:

SOURCE Alex Therapeutics

WANT YOUR COMPANY’S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3

440k+
Newsrooms &
Influencers

icon1

9k+
Virtual Media
Retailers

icon2

270k+
Newshounds
Opted In



Source link